Breaking Announcement: Carecube Device Cleared by FDA for US Market!

BOOK A DEMO

See The Carecube
in action

CUSTOMER CARE & TECHNICAL SUPPORT

(202) 743-2273

HOURS MONDAY - FRIDAY

8:00 AM - 4:00 PM PST

Contact us

Partnerships &
Certifications

GRANT FUNDING & DEVELOPMENT SUPPORT >

CERTIFICATIONS >

Documentation

DOWNLOAD EVERYTHING YOU NEED TO LEARN MORE ABOUT THE CARECUBE HERE.

Go back

Frequently asked
questions

01
IS THE CARECUBE AVAILABLE TO PURCHASE?

The Carecube is now available for purchase! Following rigorous testing and evaluation, we're proud to share that the Carecube has received FDA 510(k) clearance in the US.

02
IS THE CARECUBE A SINGLE USE DEVICE?

The Carecube is designed with specific usage guidelines to ensure safety and efficacy. While the Carecube Negative Pressure Isolation Chamber Canopy is intended for multi-patient use with a maximum of ten (10) patients, it's important to note that certain components are intended for single patient use only. Additionally, the Carecube itself is intended to be used by a single patient for up to 24 hours of continuous use. These usage instructions are in place to maintain the highest standards of patient care and infection control.

03
HOW CAN THE CARECUBE PERFORM AS A NEGATIVE-PRESSURE ISOLATION ROOM?

The Carecube is designed to maintain a negative pressure of ≤ -2.5 pascals and provides 15 or more air exchanges per hour, meeting the CDC guidance for airborne infection isolation rooms (AIIRs). Air is drawn into the device through intake filters on the roof and then passes through an H14 HEPA filter, which removes 99.997% of particulates at 0.3 micrometers. To ensure proper negative pressure, the Carecube includes a manometer with a visual alarm.

04
WHERE HAS THE CARECUBE BEEN TESTED?

The Carecube has undergone rigorous testing to ensure its safety, efficacy, and compliance with industry standards. These tests have been conducted by reputable third-party test services including Intertek, Mesa 3, Nelson Labs, and DDL.

“Every hospital and emergency department in the world should have a handful of Carecubes, even after COVID passes two or three years from now [APRIL 2020]."
DR. JONATHAN LEFF
ASSOC. PROFESSOR OF ANESTHESIOLOGY, DIRECTOR, DIVISION OF ANESTHESIOLOGY
“The Carecube allows me and my team to care for patients without the concern of contracting a virus while preserving my tactile and visual senses, thereby allowing me to perform procedures vital to patient care while remaining safe and without anxiety.”
VENKAT REDDY MANGUNTA, MD
CRITICAL CARE MEDICINE | CARDIOVASCULAR ANESTHESIA | LIEUTENANT COMMANDER, UNITED STATES NAVAL RESERVE